Your browser doesn't support javascript.
loading
Type-I interferon signaling is essential for robust metronomic chemo-immunogenic tumor regression in murine breast cancer.
Vergato, Cameron; Doshi, Kshama A; Roblyer, Darren; Waxman, David J.
Affiliation
  • Vergato C; Department of Biology, Boston University, Boston MA 02215.
  • Doshi KA; Department of Biology, Boston University, Boston MA 02215.
  • Roblyer D; Department of Biomedical Engineering, Boston University, Boston MA 02215.
  • Waxman DJ; Department of Biology, Boston University, Boston MA 02215.
Cancer Res Commun ; 2(4): 246-257, 2022 04.
Article in En | MEDLINE | ID: mdl-36187936
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Interferon Type I Limits: Animals Language: En Journal: Cancer Res Commun Year: 2022 Document type: Article Country of publication: Estados Unidos
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Interferon Type I Limits: Animals Language: En Journal: Cancer Res Commun Year: 2022 Document type: Article Country of publication: Estados Unidos